Results
14
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
14 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ROG | CHF 251.00 | 1.7% | 3.5% | CHF 201.4b | CHF 303.36 | PE18.8x | E11.5% | 3.8% | ||
NOVN | CHF 87.68 | 0.7% | 4.3% | CHF 175.3b | CHF 102.86 | PE16.6x | E7.0% | 3.7% | ||
LONN | CHF 532.40 | 0.8% | 51.3% | CHF 38.5b | CHF 636.90 | PE67.1x | E23.4% | 0.8% | ||
GALD | CHF 98.35 | 2.2% | n/a | CHF 23.4b | CHF 99.88 | PS6x | E44.6% | n/a | ||
SDZ | CHF 37.06 | 0.03% | 38.4% | CHF 16.3b | CHF 43.50 | PS1.8x | E34.9% | 1.2% | ||
BANB | CHF 57.80 | -5.5% | -11.6% | CHF 4.3b | CHF 83.57 | PE38.2x | E17.9% | 1.4% | ||
SFZN | CHF 979.00 | 0.5% | 15.2% | CHF 4.2b | CHF 1,187.67 | PE32.6x | E13.7% | 0.4% | ||
TECN | CHF 203.00 | 2.8% | -41.2% | CHF 2.6b | CHF 284.86 | PE25.7x | E14.8% | 1.5% | ||
COPN | CHF 61.20 | 3.6% | 19.3% | CHF 982.0m | CHF 97.30 | PE15.1x | E17.2% | 3.1% | ||
PPGN | CHF 28.60 | -2.2% | 63.0% | CHF 943.3m | CHF 36.25 | PS3.1x | E64.2% | 0% | ||
BSLN | CHF 41.15 | -1.1% | 14.0% | CHF 498.8m | CHF 77.25 | PS3.3x | E22.0% | 0% | ||
XLS | CHF 25.80 | -0.8% | -47.9% | CHF 148.1m | n/a | PE7x | n/a | n/a | ||
SANN | CHF 11.44 | 14.6% | 15.1% | CHF 138.5m | CHF 32.00 | PE2.2x | E35.4% | n/a | ||
OBSN | CHF 0.0012 | 0% | -98.2% | CHF 140.6k | n/a | PE0.02x | n/a | n/a |